| Stage | UTI | % of rev | URI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $219M | 100.00% | $4.9B | 100.00% | URI ×22.35 |
| Gross profit | $219M | 100.00% | $2.0B | 41.81% | UTI +58.2pp |
| Operating income | $3M | 1.48% | $1.4B | 28.80% | URI +27.3pp |
| Pre-tax income | $3M | 1.42% | $1.2B | 25.16% | URI +23.7pp |
| Net income | $2M | 1.04% | $920M | 18.80% | URI +17.8pp |
| Stage | UTI | URI | Gap · A − B |
|---|---|---|---|
| Revenue | $219M100.00% | $4.9B100.00% | URI ×22.35 |
| Gross profit | 100.00%$219M | 41.81%$2.0B | UTI +58.2pp |
| Operating income | 1.48%$3M | 28.80%$1.4B | URI +27.3pp |
| Pre-tax income | 1.42%$3M | 25.16%$1.2B | URI +23.7pp |
| Net income |
| 1.04%$2M |
| 18.80%$920M |
| URI +17.8pp |
No disclosed counterparties: URI.
None